ClinicalTrials.govpublic full text
Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC
carcinoma, hepatocellular, hepatocellular, carcinoma, tace, sorafenib, transcatheter arterial chemoembolization, nexavar, unresectable, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 810115
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.